Literature DB >> 1334807

Corticotropin-releasing factor-induced immunosuppression in human and invertebrate immunocytes.

E M Smith1, T K Hughes, P Cadet, G B Stefano.   

Abstract

1. Corticotropin-releasing factor (CRF) appears to be a potentially important signal molecule in both vertebrate and invertebrate neuroimmune and autoimmunoregulatory processes. It appears to mimic the effects of alpha-melanocyte stimulating hormone (MSH) but has a longer duration of action. 2. alpha-Helical CRF, a specific inhibitor of CRF, antagonizes CRF-induced cellular immunosuppression but is ineffective in altering MSH-induced immunosuppression. 3. Both human and Mytilus immunocytes appear to have specific CRF receptors. 4. In another experiment, both CRF and MSH antagonize tumor necrosis factor stimulation of immunocytes. Again, alpha-helical CRF antagonizes only CRF activity, further suggesting the presence of a separate CRF receptor on these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334807     DOI: 10.1007/bf00711548

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  16 in total

1.  A neuroimmunoregulatory-like mechanism responding to stress in the marine bivalve Mytilus edulis.

Authors:  G B Stefano; P Cadet; A Dokun; B Scharrer
Journal:  Brain Behav Immun       Date:  1990-12       Impact factor: 7.217

2.  Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain.

Authors:  P E Sawchenko; L W Swanson
Journal:  Fed Proc       Date:  1985-01

3.  Release of corticotropin-releasing factor from rat brain regions in vitro.

Authors:  M A Smith; G Bissette; T A Slotkin; D L Knight; C B Nemeroff
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

Review 4.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity.

Authors:  S L Foote; F E Bloom; G Aston-Jones
Journal:  Physiol Rev       Date:  1983-07       Impact factor: 37.312

5.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

Authors:  R J Valentino; S L Foote; G Aston-Jones
Journal:  Brain Res       Date:  1983-07-04       Impact factor: 3.252

6.  Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus.

Authors:  F E Bloom; E L Battenberg; J Rivier; W Vale
Journal:  Regul Pept       Date:  1982-06

7.  Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.

Authors:  M A Shipp; G B Stefano; L D'Adamio; S N Switzer; F D Howard; J Sinisterra; B Scharrer; E L Reinherz
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

8.  Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor.

Authors:  G B Stefano; P Cadet; B Scharrer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis.

Authors:  D E van Epps; L Saland
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides.

Authors:  O Duvaux-Miret; G B Stefano; E M Smith; C Dissous; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more
  5 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

Review 2.  Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

3.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

4.  Evidence for the production and action of interleukin-10 in pituitary cells.

Authors:  T K Hughes; P Cadet; P L Rady; S K Tyring; R Chin; E M Smith
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

5.  Opioid peptides and opiate alkaloids in immunoregulatory processes.

Authors:  George B Stefano; Richard M Kream
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.